Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Others

Page Path

HOME
ARTICLE CATEGORY
Others

Correspondence

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):513-515. Published online February 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044

View: 3364 Download: 57

Special thanks

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S4-S4. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0010

View: 2706 Download: 46

Preface

Yoon Jun Kim

Clin Mol Hepatol. 2023;29(Suppl):S2-S2. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0011

View: 2918 Download: 48

Preface

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S3-S3. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0014

View: 2833 Download: 52 Crossref: 1

Congratulatory remarks

Si Hyun Bae

Clin Mol Hepatol. 2023;29(Suppl):S1-S1. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0027

View: 3150 Download: 66

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”

Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2023;29(1):191-193. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0410

View: 3834 Download: 75

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0408

View: 4314 Download: 74 Web of Science: 2 Crossref: 3

Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”

Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn

Clin Mol Hepatol. 2023;29(1):185-187. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0375

View: 3752 Download: 51

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”

Won Sohn, Yong-Han Paik

Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0411

View: 3874 Download: 55 Web of Science: 1 Crossref: 1

Erratum

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2022;28(4):940-940. Published online September 7, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084.e1
Corrects: Clin Mol Hepatol 2022;28(2):276

View: 3729 Download: 68 Crossref: 2

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Do Young Kim

Clin Mol Hepatol. 2022;28(4):939-939. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2021.0277.e1
Corrects: Clin Mol Hepatol 2021;27(4):620

View: 3722 Download: 44

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim, on behalf of the Korean Association for the Study of the Liver

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 7159 Download: 95 Web of Science: 6 Crossref: 6

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 10026 Download: 232 Web of Science: 49 Crossref: 45

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 8690 Download: 218 Web of Science: 47 Crossref: 45

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights

Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina

Clin Mol Hepatol. 2020;26(4):728-735. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0202

View: 8249 Download: 209 Web of Science: 30 Crossref: 29

Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases

Yun Seok Kim, Sang Geon Kim

Clin Mol Hepatol. 2020;26(4):715-727. Published online September 22, 2020

DOI: https://doi.org/10.3350/cmh.2020.0173

View: 11972 Download: 292 Web of Science: 45 Crossref: 46

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul

Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0166

View: 6138 Download: 112 Web of Science: 15 Crossref: 14

Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell

Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong

Clin Mol Hepatol. 2020;26(4):697-704. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0152

View: 8338 Download: 180 Web of Science: 15 Crossref: 13

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0145

View: 7993 Download: 236 Web of Science: 20 Crossref: 21

Roles of the complement system in alcohol-induced liver disease

Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He

Clin Mol Hepatol. 2020;26(4):677-685. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0094

View: 8672 Download: 154 Web of Science: 22 Crossref: 25

Liver-lung axes in alcohol-related liver disease

Gavin E. Arteel

Clin Mol Hepatol. 2020;26(4):670-676. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0174

View: 7694 Download: 146 Web of Science: 14 Crossref: 15

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease

Jong Hwa Choi, Won Sohn, Yong Kyun Cho

Clin Mol Hepatol. 2020;26(4):662-669. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0163

View: 11339 Download: 190 Web of Science: 51 Crossref: 53

Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies

Seung Ha Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(4):652-661. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0160

View: 8010 Download: 147 Web of Science: 43 Crossref: 50

Predictors of steroid non-response and new approaches in severe alcoholic hepatitis

Shiv Kumar Sarin, Shvetank Sharma

Clin Mol Hepatol. 2020;26(4):639-651. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0196

View: 10547 Download: 279 Web of Science: 12 Crossref: 13

The lymphatic system in alcohol-associated liver disease

Reiichiro Kondo, Yasuko Iwakiri

Clin Mol Hepatol. 2020;26(4):633-638. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0179

View: 10327 Download: 164 Web of Science: 4 Crossref: 3

Inter-professional and inter-departmental alcoholism rehabilitation program

Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie

Clin Mol Hepatol. 2020;26(4):626-632. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0151

View: 5199 Download: 74 Web of Science: 1 Crossref: 1

Programmed cell death in alcohol-associated liver disease

Tatsunori Miyata, Laura E. Nagy

Clin Mol Hepatol. 2020;26(4):618-625. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0142

View: 13292 Download: 294 Web of Science: 65 Crossref: 71

Autophagy and liver cancer

Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding

Clin Mol Hepatol. 2020;26(4):606-617. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0169

View: 11273 Download: 283 Web of Science: 64 Crossref: 58

From intestinal dysbiosis to alcohol-associated liver disease

Beatriz Garcia Mendes, Bernd Schnabl

Clin Mol Hepatol. 2020;26(4):595-605. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0086

View: 9999 Download: 255 Web of Science: 32 Crossref: 35

Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake

Seonghwan Hwang, Tianyi Ren, Bin Gao

Clin Mol Hepatol. 2020;26(4):586-594. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0100

View: 9591 Download: 231 Web of Science: 24 Crossref: 25

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Viewed By 12752	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7683	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 7185	MAFLD: How is it different from NAFLD?
Viewed By 5736	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5681	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 369	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 354	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis